Nagy Elected President of National Genetic Counselors

October 13, 2011

COLUMBUS, Ohio – Rebecca Nagy, a certified genetic counselor and researcher at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, has been elected president of the National Society of Genetic Counselors (NSGC).​

Nagy will serve as president-elect starting Jan. 1, and assume the presidency for one year effective Jan. 1, 2013. Nagy, a member of the society since 1994, is finishing a two-year term as its secretary/treasurer. She also co-chaired the society’s familial cancer special interest group in 2008-09, representing more than 500 cancer genetic counselors nationally on issues relating to this discipline.

NSGC is the leading voice, authority and advocate for the genetic counseling profession, representing more than 2,300 masters-level health professionals. The society advances the roles of genetic counselors in health care by fostering education, research and public policy to ensure the availability of quality genetic services.

Genetic counselors are uniquely trained healthcare professionals who help people understand and adapt to medical, psychological and familial implications of genetic contributions to disease. Many also have active roles in clinical/translational research and education.

With the rapid development of new genetic tests, genetic counselors will continue to play a critical role in ensuring that the correct tests are ordered and that results are interpreted in an accurate and meaningful way, says Nagy.

“Genetics plays a key role in moving the progress of cancer research forward,” says Nagy. “All cancers arise as the result of genetic changes or mutations. Determining the genes and genetic pathways that lead to the development of a specific cancer can help us determine who may be at higher risk for certain types of cancer, and help us develop targeted therapies.”

Nagy, who has been a genetic counselor since 1997, is an assistant professor in Ohio State’s Department of Internal Medicine, Division of Human Genetics. Her research interests include genetic predisposition to non-medullary thyroid cancer.

Her clinical duties include providing comprehensive cancer genetic consultations to individuals and families with a history of cancer. Cancer Genetic consultation requires tremendous documentation of cancers in the family, risk assessment, screening recommendations, and incorporation of genetic testing as necessary. More than 400 individuals/families are seen each year in the Clinical Cancer Genetics clinic at Ohio State.

Nagy holds a bachelor’s degree in biology from the University of Iowa and a master’s degree in genetics counseling from the University of Minnesota. She also is a member of the American Society of Human Genetics.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report.

# # #

Click here for a high-resolution photo of Rebecca Nagy.

Contact: Eileen Scahill, Medical Center Public Affairs and Media Relations, 614-293-3737, or

Contact Media Staff

Amanda Harper

Director of Media Relations

614-685-5420 (direct)

614-293-3737 (main)

Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.


If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Support Those Who Support Us – October 2015

The OSUCCC – James is so grateful to the more than 400 partners who raise dollars to support care for our patients & the research that is bringing us closer to our shared vision of a cancer-free world.

The Spielman Fund: Allocating Dollars Where They Are Needed Most

When donors contribute to the Spielman Fund, they can trust that their gift will make an important and strategic impact.

Studies Suggest New Ways to Inhibit Oncogenes, Enhance Tumor-Suppressor Activity

Two new studies by OSUCCC - James cancer scientists suggest new approaches for treating cancer by inhibiting overactive cancer-promoting genes and by enhancing the activity of sluggish tumor-suppressor...